420
Articles
13.6K
Citations
4
avg. Impact Factor
59
h-index

Most Cited Articles of Division of Hematology/Oncology in 2006

TitleJournalYearCitations
Lineage-specific hematopoietic growth factorsNew England Journal of Medicine2006355
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeuticsInternational Journal of Cancer2006105
The ADAP/SKAP55 signaling module regulates T-cell receptor-mediated integrin activation through plasma membrane targeting of Rap1Molecular and Cellular Biology2006100
A role for PKCtheta in outside-in alpha(IIb)beta3 signalingJournal of Thrombosis and Haemostasis200667
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology GroupJournal of Pediatric Hematology/Oncology200665
Mismatch repair proteins as sensors of alkylation DNA damageCancer Cell200660
A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008Cancer200660
Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization processCytometry Part B - Clinical Cytometry200658
Endomitotic megakaryocytes form a midzone in anaphase but have a deficiency in cleavage furrow formationCell Cycle200640
Inherited thrombocytopenia: Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radiiSeminars in Hematology200637
Intravascular lymphoma: a role for single-agent rituximabLeukemia and Lymphoma200635
Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytesCellular Signalling200633
Transcriptional regulation of megakaryopoiesis: thrombopoietin signaling and nuclear factorsCurrent Opinion in Hematology200623
Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153Cancer200618
Comparison of Results from a Phase 1/2 Study of Lumiliximab (Anti-CD23) in Combination with FCR for Patients with Relapsed CLL with Published FCR Results.Blood200617
Separation of anti-proliferation and anti-apoptotic functions of retinoblastoma protein through targeted mutations of its A/B domainPLoS ONE200616
EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosineBlood200613
Phosphorylation site mutated RB exerts contrasting effects on apoptotic response to different stimuliOncogene200612
Hematopoietic growth factors, signaling and the chronic myeloproliferative disordersCytokine and Growth Factor Reviews200610
Focal radiation therapy of brain metastases after complete surgical resectionMedical Oncology200610